Eden Research plc (AIM:EDEN)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 16.87M +13.0% |
| Revenue (ttm) | 3.88M -5.8% |
| Net Income | -1.96M |
| EPS | -0.00 |
| Shares Out | 803.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,671,498 |
| Open | 2.100 |
| Previous Close | 2.000 |
| Day's Range | 2.018 - 2.200 |
| 52-Week Range | 1.900 - 5.000 |
| Beta | 1.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Eden Research
Eden Research plc, together with its subsidiaries, biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health, and consumer products industries in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consumer products, such as head-lice treatment, deodorants, odour neutralizer, and fr... [Read more]
Financial Performance
In fiscal year 2026, Eden Research's revenue was 3.88 million, a decrease of -9.78% compared to the previous year's 4.30 million. Losses were -1.96 million, 2.67% more than in 2024.
Financial StatementsNews
AIM Market Roundup: Zenova, CAP-XX, Eden Research
Zenova, CAP-XX, Eden Research are today's top risers, while Revolution Beauty, Arkle Resources take the biggest fall on London's AIM market